Latin America Ostomy Dressings Market worth USD 0.40 billion by 2030

 The Latin America ostomy dressings market is projected to reach USD 0.40 billion by 2030 from USD 0.30 billion in 2025, at a CAGR of 6.4% during the forecast period. Market growth is driven by several key factors, including the rising incidence of colorectal and bladder cancers, the increasing prevalence of inflammatory bowel diseases, and a rapidly aging population that requires long-term ostomy care. Additionally, improvements in public healthcare coverage and greater accessibility to surgical procedures have led to an increase in the number of ostomies performed across various regions. Furthermore, there is a growing trend toward home care and patient education, along with enhanced availability of new skin barrier and pouching systems, all of which contribute to the increased use of these products.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200293770

KEY TAKEAWAYS

  • Based on country, Brazil accounted for the largest share of 32.5% of the Latin America ostomy dressings market in 2024.
  • Based on product, the bags/pouches segment accounted for the largest share, 67.1%, of the Latin America ostomy dressings market in 2024.
  • Based on application, the cancer (colon & bladder) segment accounted for the largest share of 42.8% of the Latin America ostomy dressings market in 2024.
  • Based on end user, the hospitals & specialty clinics segment held the largest share of 45.0% of the Latin America ostomy dressings market during the forecast period.
  • Coloplast A/S (Denmark), Convatec Group Plc (UK), and Hollister Incorporated (US) were recognized as star players due to their established strong product portfolios & geographic presence across Latin America.

Colostomy bags segment accounted for the largest share of the bags/pouches segment in the Latin America ostomy dressings market in 2024.

The Latin America ostomy dressings market is categorized by product type into bags/pouches, skin barrier sheets, skin barrier rings, film dressings, and other products. In 2024, the bags/pouches segment accounted for the largest share of the market. This segment is further divided into colostomy bags, ileostomy bags, and urostomy bags. Among these, colostomy bags held the major share in 2024, primarily due to the rising incidence of colorectal cancer in the region. According to GLOBOCAN 2022, colorectal cancer is one of the most prevalent cancers in Latin America, with incidence rates exceeding 1.14 million cases in 2022. This substantial patient base drives high demand for colostomy surgeries. Such surgeries often result in temporary or permanent colostomies, leading to a consistent and sustained demand for colostomy bags. Additionally, patients undergoing colostomies typically require frequent use and replacement of these bags, further increasing consumption per patient. The combination of an increasing volume of procedures, prolonged use, and the ongoing need for colostomy bags reinforces their leading position in the ostomy dressings market.

Home care settings segment is expected to register the highest CAGR during the forecast period.

The Latin America ostomy dressings market is segmented based on end users into three categories: hospitals & specialty clinics, home care settings, and ambulatory surgical centers. Among these, the home care settings segment is expected to experience the fastest CAGR during the forecast period. This growth can be attributed to the increasing trend of post-surgical care being provided outside hospital facilities. Factors such as early discharge practices, rising chronic disease cases, and the need for prolonged ostomy care are driving greater demand for home care. Patients prefer home care because it offers convenience, privacy, and an improved quality of life. Additionally, the development of user-friendly skin protection and extended wear ostomy products is enhancing the safety of self-management and caregiver-assisted care. Moreover, increased patient awareness, the rise in home healthcare services, and the need for hospitals to reduce costs are contributing to the shift of ostomy care toward home care settings, thereby accelerating the growth of this segment.

Brazil is anticipated to experience rapid growth during the forecast period

The Latin America ostomy dressings market is divided into Brazil, Mexico, Argentina, Colombia, Chile, and Peru. Among these, Brazil is expected to grow at the fastest CAGR during the forecast period. This is due to the combination of increasing disease burden, rapid population aging, and extensive public healthcare coverage. The rising number of colon and bladder cancer cases, along with a steep increase in inflammatory bowel disease prevalence, has led to a greater number of ostomy procedures and long-term product usage. The increasing elderly population is driving the demand for healthcare services, as older individuals are at a higher risk of developing oncological and gastrointestinal diseases. Additionally, Brazil’s Unified Health System (SUS) covers cancer treatment costs for about 75% of its population, making surgeries and follow-up care more accessible. As a result, people are using ostomy dressing products more frequently, and the market is poised for accelerated growth.

Key Market Players

The key players in the Latin America ostomy dressings market are Coloplast A/S (Denmark), Convatec Group PLC (UK), Hollister Incorporated (US), B. Braun SE (Germany), Solventum (US), Owens & Minor, Inc. (US), Advin Health Care (India), Salts Healthcare (UK), and Welland Medical Limited (UK), among others.

RECENT DEVELOPMENTS

  • December 2025 : Solventum announced that it has earned the Diamond Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC), the highest distinction for supply chain resilience in the healthcare sector. This recognition underscores the robustness of Solventum’s MedSurg segment, validating its capability to consistently supply critical healthcare products and maintain continuity of patient care, even amid significant supply chain disruptions.
  • May 2024 : Coloplast A/S expanded its SenSura Mio portfolio with the launch of SenSura Mio in black and SenSura Mio Convex Soft with Flex coupling. These additions reflect the company’s focus on product innovation and personalization, enhancing choice and comfort for people living with a stoma.
  • February 2024 : Convatec announced the initial launch of Esteem Body with Leak Defense in Italy, marking the first market introduction. The company plans to expand into the US in April, followed by a phased rollout across emerging markets worldwide.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=200293770


Comments

Post a Comment

Popular posts from this blog

Adhesion Barrier Industry worth $0.9 billion by 2028, with a CAGR of 7.4%

  The report   " Adhesion Barrier Market  by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (Film, Gel, Liquid), Procedure (Abdominal, Cardiovascular, Gynae, Neurology), End User (Hospitals, Clinics & ASC), Region- Global Forecast to 2028" , is valued at an estimated USD 0.7 billion in 2023 and is projected to reach USD 0.9 billion by 2028, at a CAGR of 7.4% during the forecast period. The main drivers of this market's expansion are the rising number of surgeries and sports-related injuries, an increasing elderly population, and a growing understanding by of the adhesion formation and health issues linked to adhesions. On the other hand, during the forecast period, it is projected that surgeons' resistance to using adhesion barriers will impede market expansion. Browse 207 market data Tables and 50 Figures spread through 238 Pages and in-depth TOC on  "Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (F...
Read more

Exploring the Versatile Uses of Liquid Biopsies in Modern Medicine

Image
 In recent years, liquid biopsy has emerged as a groundbreaking tool in the field of medicine, offering a less invasive alternative to traditional tissue biopsies. This innovative technique, which involves the analysis of biomarkers in bodily fluids such as blood, urine, or saliva, is revolutionizing the way we diagnose, monitor, and treat various diseases. Let’s delve into the versatile uses of liquid biopsies and how they are transforming healthcare. Download PDF Brochure 1. Cancer Detection and Diagnosis One of the most significant uses of liquid biopsy is in the early detection and diagnosis of cancer. Traditional tissue biopsies can be invasive, painful, and sometimes risky. In contrast, liquid biopsies offer a non-invasive way to detect cancerous cells or DNA fragments (circulating tumor DNA or ctDNA) in the bloodstream. This allows for the identification of cancer at an earlier stage, often before symptoms appear, which can lead to more effective treatment options and i...
Read more

Exploring the Impact of Animal Genetics Testing: Revolutionizing Animal Breeding and Health

Image
 In recent years, animal genetics testing has emerged as a game-changer in the field of veterinary science and animal breeding. By unlocking the genetic makeup of animals, this innovative technology allows for a deeper understanding of their traits, health, and lineage. The implications of these insights are profound, offering significant benefits for breeders, farmers, veterinarians, and pet owners alike. Download PDF Brochure Understanding Animal Genetics Testing Animal genetics testing involves analyzing an animal's DNA to identify specific genetic markers associated with various traits and conditions. These tests can be used to determine parentage, predict the likelihood of certain diseases, and even select for desirable traits in breeding programs. The technology behind these tests has advanced rapidly, making them more accessible and affordable than ever before. Applications in Breeding One of the most significant applications of animal genetics testing is in selecti...
Read more